Literature DB >> 12734424

Hedgehog signaling: progenitor phenotype in small-cell lung cancer.

D Neil Watkins1, David M Berman, Stephen B Baylin.   

Abstract

Recently, we have shown that small cell lung cancer (SCLC) is dependent on activation of Hedgehog signaling, an embryonic pathway implicated in development, morphogenesis and the regulation of stem cell fates. These findings form the framework for an emerging view of cancer as a process of aberrant organogenesis in which progenitor/ stem cells escape dependence on niche signaling through mutation in genes such as Ptch, or through persistent activation of progenitor cell pathways. Interestingly, the normally quiescent airway epithelial compartment uses the Hh pathway to repopulate itself when challenged by injury. How Hh signaling works to promote the malignant phenotype promises to be as important biologically as the promise of Hh pathway inhibitors are clinically.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12734424

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  33 in total

Review 1.  Next stop, the twilight zone: hedgehog network regulation of mammary gland development.

Authors:  Michael T Lewis; Jacqueline M Veltmaat
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-04       Impact factor: 2.673

2.  Novel systemic therapies for small cell lung cancer.

Authors:  Charles M Rudin; Christine L Hann; Craig D Peacock; D Neil Watkins
Journal:  J Natl Compr Canc Netw       Date:  2008-03       Impact factor: 11.908

3.  Expression of hedgehog pathway components in prostate carcinoma microenvironment: shifting the balance towards autocrine signalling.

Authors:  Vassiliki Tzelepi; Maria Karlou; Sijin Wen; Anh Hoang; Christopher Logothetis; Patricia Troncoso; Eleni Efstathiou
Journal:  Histopathology       Date:  2011-06       Impact factor: 5.087

4.  Glioma-associated oncogene family zinc finger 1 expression and metastasis in patients with head and neck squamous cell carcinoma treated with radiation therapy (RTOG 9003).

Authors:  Christine H Chung; James J Dignam; M Elizabeth Hammond; Alexander C Klimowicz; Stephanie K Petrillo; Anthony Magliocco; Richard Jordan; Andy Trotti; Sharon Spencer; Jay S Cooper; Quynh-Thu Le; K Kian Ang
Journal:  J Clin Oncol       Date:  2011-02-28       Impact factor: 44.544

5.  Hedgehog signaling pathway: the must, the maybe and the unknown.

Authors:  Paul Zarogoulidis; Katerina Zarampouka; Haidong Huang; Kaid Darwiche; Yong Huang; Antonis Sakkas; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

6.  A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer.

Authors:  M Catherine Pietanza; Anya M Litvak; Anna M Varghese; Lee M Krug; Martin Fleisher; Jerrold B Teitcher; Andrei I Holodny; Cami S Sima; Kaitlin M Woo; Kenneth K Ng; Helen H Won; Michael F Berger; Mark G Kris; Charles M Rudin
Journal:  Lung Cancer       Date:  2016-04-26       Impact factor: 5.705

Review 7.  Lung cancer stem cells: progress and prospects.

Authors:  Amber Lundin; Barbara Driscoll
Journal:  Cancer Lett       Date:  2012-08-17       Impact factor: 8.679

8.  Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features.

Authors:  Michelle Heath; Natalia Jaimes; Bianca Lemos; Arash Mostaghimi; Linda C Wang; Pablo F Peñas; Paul Nghiem
Journal:  J Am Acad Dermatol       Date:  2008-03       Impact factor: 11.527

Review 9.  Paraneoplastic endocrine syndromes: a review.

Authors:  Ronald A DeLellis; Ling Xia
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

10.  Overexpression of sonic Hedgehog in the lung mimics the effect of lung injury and compensatory lung growth on pulmonary Sca-1 and CD34 positive cells.

Authors:  Anja Krause; Yaqin Xu; Ju Joh; Ralf Hubner; Austen Gess; Thomas Ilic; Stefan Worgall
Journal:  Mol Ther       Date:  2009-10-27       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.